Standout Papers
- cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. (1980)
Citation Impact
4 by Nobel laureates 28 from Science/Nature 55 standout
Citing Papers
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
2021 StandoutScience
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Works of Griswold Dp being referenced
Establishment of cross-resistance profiles for new agents.
1983
Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.
1972
Author Peers
| Author | Oncology | Molecular Biology | Organic Chemistry | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Griswold Dp | 492 | 340 | 57 | 187 | 19 | 878 | |
| Mohammad Javad Esfahani | 6 | 6 | 1 | 21 | 446 | ||
| M. Shioden | 4 | 11 | |||||
| Laure Marvin | 20 | 580 | 37 | 23 | 19 | 1.0k | |
| Franz Starlinger | 3 | 1 | 10 | 515 | |||
| Lorenzo Scappaticci | 1 | 1 | 7 | 25 | 300 |
All Works
Loading papers...